Next Article in Journal
Comparative Analysis of Factors Affecting Quality of Community-Based Care Services in Korea
Next Article in Special Issue
Native and Indigenous Populations and Gastric Cancer: A Worldwide Review
Previous Article in Journal
The Temporal and Spatial Distributions and Influencing Factors of Transboundary Pollution in China
Previous Article in Special Issue
Cancer Screening among Rural People Who Use Drugs: Colliding Risks and Barriers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 19
Issue 8
10.3390/ijerph19084642
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model

by
Grace X. Ma
1,2,*,
Lin Zhu
1,2,
Wenyue Lu
1,3,
Yin Tan
1,
Jade Truehart
1,
Cicely Johnson
4,
Elizabeth Handorf
5,
Minhhuyen T. Nguyen
5,
Ming-Chin Yeh
6 and
Min Qi Wang
7
1
Center for Asian Health, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
2
Department of Urban Health and Population Science, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
3
Department of Sociology, College of Liberal Arts, Temple University, Philadelphia, PA 19120, USA
4
Center for Cancer Health Disparities Research (CCHDR), Hunter College, City University of New York, New York, NY 10065, USA
5
Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA 19111, USA
6
Nutrition Program, Hunter College, City University of New York, New York, NY 10065, USA
7
School of Public Health, University of Maryland, College Park, MD 20742, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(8), 4642; https://doi.org/10.3390/ijerph19084642
Submission received: 12 February 2022 / Revised: 5 April 2022 / Accepted: 8 April 2022 / Published: 12 April 2022
(This article belongs to the Special Issue Cancer Health Disparities and Public Health)
Review Reports Versions Notes

Abstract

:
Background: Compared to non-Hispanic whites, Asian Americans are 60% more likely to die from the disease. Doctor visitation for chronic hepatitis B (CHB) infection every six months is an effective approach to preventing liver cancer. Methods: This study utilized baseline data from an ongoing randomized controlled clinical trial aimed at improving long-term adherence to CHB monitoring/treatment. Guided by the information-motivation-behavioral skills (IMB) model, we examined factors associated with CHB monitoring adherence among Asian Americans with CHB. Multivariable logistic regression was conducted to test the associations. Results: The analysis sample consisted of 382 participants. Multivariable logistic regression showed that HBV knowledge (OR = 1.24, p < 0.01) and CHB-management motivation (OR = 1.06, p < 0.05) are significant predictors of having a doctor’s visit in the past six months. Both factors were positively associated with the likelihood of having had blood tests for HBV in the past six months. Conclusion: We found that greater HBV-related knowledge and CHB-management motivation are significantly associated with performing CHB-monitoring behaviors in the past six months. The findings have critical implications for the development and implementation of evidence-based interventions for CHB monitoring and liver cancer prevention in the Asian American community.

1. Introduction

Asian Americans are disproportionately affected by liver cancer and viral hepatitis [1,2,3]. The incidence of liver and intrahepatic bile duct (IBD) cancer is much higher among Asian Americans than in non-Hispanic whites (19.9 versus 10.8 per 100,000 men, and 7.4 versus 3.7 per 100,000 women) [4]. Asian Americans are also 70% more likely to die from liver and IBD cancer than their non-Hispanic white counterparts [4]. One major contributor to such alarming disparities is chronic hepatitis B (CHB) infection. Hepatitis B virus (HBV) infection is the leading cause of cirrhosis, and hepatocellular carcinoma (HCC) [2,5,6,7,8,9,10,11,12]. About 2.2 million individuals in the U.S. are living with CHB infection. Up to 70% of infected individuals are from non-U.S.-born populations, with the highest prevalence among persons from Asia (58%) [12,13,14,15,16,17,18,19,20,21,22,23]. Prevalence rates of CHB in Asian Americans range from 8% to 13%, a figure that is significantly higher than the 1% rate observed in non-Hispanic Whites (NHW) [1,22].
Regular monitoring for CHB is critical for tracking disease progression, treatment adherence, and risk for the development of HCC [24]. Guidelines from the American Association for the Study of Liver Disease (AASLD) recommend regular monitoring of individuals living with HBV at six-month intervals, with an assessment of liver function, HBV viral load, ultrasound, and alpha-fetoprotein (AFP) levels [25]. Routine monitoring for liver disease activity can inform treatment decisions aimed at reducing HCC risk [25]. Unfortunately, adherence to HCC surveillance has been suboptimal among Asian Americans, with less than 50% of those who are eligible to undergo regular CHB monitoring [26,27,28]. Several studies have suggested that limited English proficiency, not having a regular source of care, and lack of health insurance coverage are among the major barriers that prevent Asian Americans from receiving regular CHB monitoring [28,29,30,31,32,33].
Research has also found that low knowledge of and lack of awareness of hepatitis and liver cancer risk is another significant predictor of poor monitoring in various Asian American subgroups [33,34,35,36]. In addition, psychosocial factors, such as self-efficacy, and motivation have been suggested as predictors of adherence to CHB monitoring [29,37,38], yet empirical evidence was lacking. In recent years, a theoretical model known as the information-motivation-behavioral skills (IMB) model has been used to better explain factors that influence healthy behavior [39]. The IMB model draws from rational behavior theory and social cognitive theory to propose that healthy behaviors are based on three components: information, motivation, and behavioral skills. Information refers to an accurate knowledge of the specific healthy behavior. Motivation refers to personal and social motivation to perform a specific behavior. Behavioral skills include an individual’s self-efficacy and confidence in performing the behavior [40]. While the IMB model has been widely used in research on the prevention and management of HIV/AIDS [41,42,43] and diabetes [44,45], it has not been applied to adherence to CHB monitoring, to the best of our knowledge.
Guided by the IMB model, we examined factors associated with CHB monitoring adherence among Asian Americans living with CHB. Our findings advance the understanding of relationships among cognitive, emotional, and behavioral skills factors that influence CHB monitoring behaviors in the IMB model and have critical implications for the development and implementation of evidence-based interventions for CHB monitoring and liver cancer prevention in the Asian American community.

2. Materials and Methods

2.1. Study Participants

From March 2019 to March 2020, 382 Asian American CHB patients, including 298 Chinese Americans and 84 Vietnamese Americans, were enrolled through combined recruitment approaches in the Greater Philadelphia Area and New York City to participate in a randomized control trial on long-term CHB monitoring and antiviral treatment adherence. The eligibility criteria for new subjects were: (1) aged 18 or above; (2) self-identified Chinese or Vietnamese ethnicity; (3) CHB infection with positive HBV surface antigen (HBsAg); (4) CHB diagnosed for at least 12 months; (5) non-compliance with HBV monitoring and treatment guidelines for more than 6 months; (6) cell phone accessible by receiving text messaging; (7) not enrolled in any other HBV Management intervention (to prevent a potential program impact). We excluded cases with missing data on HBV monitoring behaviors. The analysis sample consisted of 378 participants, including 295 Chinese and 83 Vietnamese Americans.

2.2. Procedures

The current study used the data collected from the baseline survey of the larger trial. Baseline data collection was conducted from April 2019 to March 2020 through a face-to-face survey, which took approximately 30 min to complete. The survey questionnaire was developed in English, translated into Mandarin, Cantonese, and Vietnamese, and back-translated into English by bilingual community health educators on the research team. The back-translated version was compared with the English version to verify that the questions were properly translated. Participants completed the survey in their preferred language. During the survey, trained bilingual community health educators provided language support to address questions from the participants. The study was approved by the Western Institutional Review Board (WIRB) (protocol #: 20190122). All participants read and signed informed consent forms to participate in the study and received a $25 incentive for completing the baseline survey.

2.3. Measures

The primary outcomes were HBV monitoring measures, including doctor visits for CHB and HBV blood testing in the past 6 months. Doctor visits for HBV were measured with one question “Did you see a doctor to check your hepatitis B infection condition during the past six months?” The answers were dichotomous (yes or no). HBV blood testing was measured with the question “Have you had blood tests (e.g., HBV DNA, Liver function, Alpha-fetoprotein) in the past six months?” The answers were dichotomous (yes or no). For both questions, “I don’t know” was coded as “no”.
HBV-related knowledge was examined with a 10-item scale that previously was validated in Asian Americans with CHB [46]. Specifically, participants answered “False”, “True”, or “Don’t know” to 10 HBV knowledge statements, such as “People will feel sick if they are infected with hepatitis B” and “Regular monitoring and treatment can reduce liver damage caused by chronic hepatitis B”. One point was assigned to correct answers and zero points to wrong answers. We computed the accumulated HBV knowledge score by summing the points from all 10 items. The final knowledge score ranged from 0 to 10, with a higher numeric value indicating a higher level of HBV-related knowledge.
CHB-Management motivation was accessed with 10 items on a five-point Likert scale (from 1, “strongly agree”, to 5, “strongly disagree”). Examples of the items include “I don’t like taking my HBV medications because they remind me that I am HBV+” and “My healthcare provider doesn’t give me enough support when it comes to taking my medications as prescribed”. The total motivation score was the summation of the responses to the 10 items. The score ranged from 5 to 50, with a higher numeric value indicating a higher level of motivation related to CHB management.
CHB-Management self-efficacy was measured with 13 items adapted from the medical adherence self-efficacy score (MASES) [47], asking participants how confident they were in taking HBV medications under various situations. The answers ranged from 0 “not at all” to 3 “extremely sure”, which were summed up to compute the final self-efficacy score. The self-efficacy score ranged from 0 to 26, with a higher numeric value indicating a greater confidence in taking HBV medications as recommended by doctors.
Socioeconomic factors, specifically, participants’ age in years, gender, ethnicity, U.S. residency length, marital status, education levels, employment status, annual household income, health insurance coverage, and English-speaking proficiency were included as predictors of HBV management outcomes.

2.4. Statistical Analysis

We conducted a descriptive analysis of the sociodemographic characteristics and the psychosocial factors of the analysis sample. We also conducted chi-square tests and t-tests to examine associations between sociodemographic/psychosocial factors and CHB management behaviors (doctor’s visit and blood test). We then fitted two multilevel mixed-effects generalized linear models (GLMs) to identify the significant predictors of the outcomes while accounting for the sample clustering by recruitment site and state. All data analyses were conducted using Stata 16 [48]. A p value that was smaller than 0.05 was considered statistically significant.

3. Results

Table 1 presents the sociodemographic characteristics and psychosocial factors of the participants, as well as their association with CHB monitoring, specifically doctor’s visit in the past six months. Bivariate analyses showed that being Chinese (vs. Vietnamese), having a high school or lower education (vs. college or above), having health insurance, and having a regular physician were significantly associated with higher rates of having visited a doctor for CHB in the past six months. In addition, having a higher HBV-related knowledge score, a higher CHB-management motivation score, and a higher CHB-managed self-efficacy were significantly associated with higher rates of having visited a doctor for CHB in the past six months.
Table 2 presents the sociodemographic characteristics and psychosocial factors of the participants, as well as their association with having had blood tests for their CHB infection in the past six months. Bivariate analyses showed similar associations with those in Table 1. Specifically, being Chinese (vs. Vietnamese), having a high school or lower education (vs. college or above), having health insurance, and having a regular physician were significantly associated with higher rates of having had blood tested for CHB in the past six months. In addition, having a higher HBV-related knowledge score, a higher CHB-management motivation score, and a higher CHB-managed self-efficacy were significantly associated with higher rates of blood testing for CHB in the past six months. Other characteristics, including household income, were not significantly associated with the outcome.
Table 3 presents the results of the multivariate logistic regression on a doctor’s visit and blood testing in the past six months. Having a regular physician (OR = 3.81, p < 0.05) was significantly associated with a higher likelihood of having visited a doctor for CHB, while Chinese ethnicity (vs Vietnamese), having a high school or lower degree (vs. college degree or above), and having health insurance were significant predictors of having had blood tests done in the past six months. With regard to psychosocial factors, higher HBV-related knowledge and higher CHB-management motivation were significantly associated with a higher likelihood of both outcomes—having had a doctor’s visit and blood tests in the past six months. CHB-management self-efficacy was not a significant predictor for either outcome.

4. Discussion

The present study examined factors associated with CHB monitoring adherence among Chinese and Vietnamese Americans living with CHB. More specifically, we examined adherence within the framework of the IMB model to better understand the impact of cognitive, emotional, and behavioral factors on the pursuit of healthy behaviors. The results of our analyses indicate that HBV knowledge and CHB-management motivation are significant predictors of having a doctor’s visit in the past six months for both Chinese and Vietnamese American study participants. We further found that HBV knowledge and CHB-management motivation are positively associated with the likelihood of having had blood tests for HBV in the past 6 months in these populations.
Previous studies have found that low levels of knowledge and lack of awareness about hepatitis and the risk of liver cancer are important predictors of suboptimal hepatitis monitoring in different subgroups of Asian Americans [33,34,35,36]. Our data support these associations, specifically in that a higher HBV-related knowledge score was significantly associated with higher rates of having visited a doctor for CHB in the past six months and with higher rates of blood testing for CHB in the last six months. Research has also suggested that adherence to CHB monitoring can be predicted by motivation and psychosocial factors (e.g., self-confidence and self-efficacy) [29,37,38]. Our findings also support these observations, with higher CHB-management motivation score and higher CHB-managed self-efficacy being significantly associated with higher rates of having visited a doctor and undergoing blood testing for CHB in the last six months.
In addition, our findings confirmed the significant roles of having health insurance and having a regular physician in CHB monitoring found in previous studies [29,31]. Specifically, we found three-fold differences in the odds of having an office visit and having blood tests done for their CHB conditions by insurance status and whether they had a regular physician. More efforts are needed in outreach, education, and service to Asian Americans without health insurance or a regular source of care.
Household income was not significantly associated with CHB monitoring in bi-variate analysis. Previous research has generated conflicting findings in the relationship between household income level and healthcare utilization among Asian Americans [49,50]. Our findings suggest that individual level education and healthcare access potentially played bigger roles in influencing CHB monitoring behaviors than did household income.
A key strength of the present study is the use of the IMB model, which incorporates components of rational behavior theory and social cognitive theory. The IMB model proposes that engaging in a healthy behavior requires accurate knowledge of the behavior, personal and social motivation to perform the behavior, and individual self-efficacy and confidence to execute the behavior [40]. To the best of our knowledge, the present study is the first to apply the IMB model to CHB monitoring adherence. Another major strength of our study is the baseline data, which was drawn from a randomized control trial on long-term CHB monitoring and antiviral treatment adherence in a unique study population, encompassing Chinese and Vietnamese Americans, from the Greater Philadelphia Area and New York City.
The findings of this study serve as important baseline data for the large-scale randomized control trial intervention. The culturally tailored, multilevel components that we have designed and implemented are aimed to address the barriers that Asian Americans with CHB experience on the healthcare system level, provider level, community level, and individual level. The multilevel approach is critical in the empowerment of this vulnerable population, especially in the contexts of structural racism, anti-Asian discrimination, and other difficulties exacerbated by the COVID-19 pandemic [51,52]. More efforts are needed in creating structural level interventions to facilitate policy and systemic change to improve access to care for the underprivileged and medically underserved populations [52].

5. Conclusions

In conclusion, we examined factors associated with CHB monitoring adherence among Asian Americans living with CHB, using the IMB model as a guide. Our primary finding, that higher HBV-related knowledge and greater CHB-management motivation are significantly associated with carrying out CHB-monitoring behaviors, supports observations from previous studies and offers new insight into cognitive, emotional, and behavioral skills factors that influence healthy behaviors among Chinese and Vietnamese Americans. Moreover, our findings could have important implications for the development of novel evidence-based interventions for CHB monitoring and liver cancer prevention in the Asian American community.

Author Contributions

Conceptualization, G.X.M., L.Z., Y.T. and M.Q.W.; Data Curation, L.Z., M.Q.W. and E.H.; Formal analysis, E.H. and L.Z.; Investigation, L.Z., W.L., C.J. and M.T.N.; Methodology, G.X.M., L.Z. and W.L.; Project administration, L.Z., W.L. and Y.T.; Resources, G.X.M.; Software, G.X.M., E.H. and M.Q.W.; Supervision, G.X.M. and Y.T.; Validation, G.X.M.; Visualization, L.Z., W.L., Y.T. and G.X.M.; Writing—original draft, L.Z., W.L., J.T. and C.J.; Writing—review and editing, L.Z., W.L., J.T., M.-C.Y. and G.X.M. All authors have read and agreed to the published version of the manuscript.

Funding

This study supported by TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704 (5) from the National Cancer Institute of National Institutes of Health (NCI/NIH).

Institutional Review Board Statement

The study has been approved by the Western Institutional Review Board (protocol #: 20190122).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors would like to acknowledge Sarit Golub and Chibuzo Enemchukwu from Hunter College for their contribution in study design, intervention, and measurement development.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, M.S.; Dang, J. Hepatitis B among Asian Americans: Prevalence, Progress, and Prospects for Control. World J. Gastroenterol. 2015, 21, 11924–11930. [Google Scholar] [CrossRef] [PubMed]
  2. El-Serag, H.B. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 2012, 142, 1264–1273.e1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Thompson, C.A.; Gomez, S.L.; Hastings, K.G.; Kapphahn, K.; Yu, P.; Shariff-Marco, S.; Bhatt, A.S.; Wakelee, H.A.; Patel, M.I.; Cullen, M.R.; et al. The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity. Cancer Epidemiol. Prev. Biomark. 2016, 25, 1371–1382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. U.S. Department of Health and Human Services. The Office of Minority Health Cancer and Asian Americans. Available online: https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=46 (accessed on 25 August 2021).
  5. World Health Organization. Hepatitis B. Available online: http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed on 7 April 2016).
  6. Sharma, S.; Carballo, M.; Feld, J.J.; Janssen, H.L.A. Immigration and Viral Hepatitis. J. Hepatol. 2015, 63, 515–522. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Nguyen, K.; Van Nguyen, T.; Shen, D.; Xia, V.; Tran, D.; Banh, K.; Ruan, V.; Hu, K.-Q. Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans via Serial Community Serologic Testing. J. Immigr. Minor. Health Cent. Minor. Public Health 2015, 17, 13–20. [Google Scholar] [CrossRef] [PubMed]
  8. Di Bisceglie, A.M. Hepatitis B and Hepatocellular Carcinoma. Hepatology 2009, 49, S56–S60. [Google Scholar] [CrossRef] [Green Version]
  9. Rossi, C.; Shrier, I.; Marshall, L.; Cnossen, S.; Schwartzman, K.; Klein, M.B.; Schwarzer, G.; Greenaway, C. Seroprevalence of Chronic Hepatitis B Virus Infection and Prior Immunity in Immigrants and Refugees: A Systematic Review and Meta-Analysis. PLoS ONE 2012, 7, e44611. [Google Scholar] [CrossRef] [Green Version]
  10. El–Serag, H.B.; Rudolph, K.L. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology 2007, 132, 2557–2576. [Google Scholar] [CrossRef]
  11. Hepatitis B Foundation. Hepatitis B Foundation: FAQ: General Info. Available online: http://www.hepb.org/patients/general_information.htm#ques3 (accessed on 7 April 2016).
  12. Lavanchy, D. Hepatitis B Virus Epidemiology, Disease Burden, Treatment, and Current and Emerging Prevention and Control Measures. J. Viral Hepat. 2004, 11, 97–107. [Google Scholar] [CrossRef]
  13. Centers for Disease Control and Prevention. Viral Hepatitis—CDC Recommendations for Specific Populations and Settings: Asian and Pacific Islanders. Available online: http://www.cdc.gov/hepatitis/populations/api.htm (accessed on 7 April 2016).
  14. Centers for Disease Control and Prevention. Division of Viral Hepatitis Home Page | Division of Viral Hepatitis | CDC. Available online: http://www.cdc.gov/hepatitis/index.htm (accessed on 26 September 2016).
  15. Cohen, C.; Caballero, J.; Martin, M.; Weerasinghe, I.; Ninde, M.; Block, J. Eradication of Hepatitis B: A Nationwide Community Coalition Approach to Improving Vaccination, Screening, and Linkage to Care. J. Community Health 2013, 38, 799–804. [Google Scholar] [CrossRef]
  16. Dan, C.; Tai, K.; Wang, S.H.; Caballero, J.; Martin, M.; Lavilla, S.; Agbayani, N. Addressing Hepatitis B: Community Health Centers, Partnerships and the Affordable Care Act. J. Health Care Poor Underserved 2012, 23, 507–512. [Google Scholar] [CrossRef] [PubMed]
  17. Institute of Medicine of the National Academies (IOM). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C; Colvin, H.M., Mitchell, A.E., Eds.; National Academies Press: Washington, DC, USA, 2010; ISBN 978-0-309-15368-3. [Google Scholar]
  18. Kowdley, K.V.; Wang, C.C.; Welch, S.; Roberts, H.; Brosgart, C.L. Prevalence of Chronic Hepatitis B among Foreign-Born Persons Living in the United States by Country of Origin. Hepatology 2012, 56, 422–433. [Google Scholar] [CrossRef] [PubMed]
  19. National Alliance of State & Territorial Aids Directors. The Affordable Care Act and the Silent Epidemic: Increasing the Viral Hepatitis Response Through Health Reform; NASTA: Washington, DC, USA, 2013. [Google Scholar]
  20. US Department of Health and Human Services. White House Initiative on Asian Americans and Pacific Islanders. HHS Plan for Asian American, Native Hawaiian and Pacific Islander (AANHPI) Health—The Office of Minority Health. Available online: https://minorityhealth.hhs.gov/omh/Content.aspx?lvl=3&lvlid=63&ID=8800 (accessed on 3 April 2017).
  21. American Cancer Society. Liver Cancer. Available online: http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-prevention (accessed on 28 September 2016).
  22. Centers for Disease Control and Prevention. Asian Americans and Hepatitis B. Available online: http://www.cdc.gov/Features/AAPIHepatitisB/ (accessed on 27 March 2014).
  23. U.S. Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021–2025); U.S. Department of Health and Human Services: Washington, DC, USA, 2020. [Google Scholar]
  24. Toy, M.; Demirci, U.; So, S. Preventing Hepatocellular Carcinoma: The Crucial Role of Chronic Hepatitis B Monitoring and Antiviral Treatment. Hepatic Oncol. 2014, 1, 255–257. [Google Scholar] [CrossRef]
  25. Terrault, N.A.; Lok, A.S.F.; McMahon, B.J.; Chang, K.-M.; Hwang, J.P.; Jonas, M.M.; Brown, R.S.; Bzowej, N.H.; Wong, J.B. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology 2018, 67, 1560–1599. [Google Scholar] [CrossRef] [PubMed]
  26. Abesamis-Mendoza, N.; Kadag, C.; Nadal, K.; Ursua, R.; Gavin, N.; Divino, L.A. Community Health Needs & Resource Assessment: An Exploratory Study of Filipino Americans in the New York Metropolitan Area. NYU Sch. Med. Inst. Community Health Res. 2007. Available online: https://med.nyu.edu/sites/default/files/asian-health2/chnra_filipinos_0.pdf (accessed on 1 December 2021).
  27. Juday, T.; Tang, H.; Harris, M.; Powers, A.Z.; Kim, E.; Hanna, G.J. Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment. J. Gen. Intern. Med. 2011, 26, 239–244. [Google Scholar] [CrossRef] [Green Version]
  28. Zhang, S.; Ristau, J.T.; Trinh, H.N.; Garcia, R.T.; Nguyen, H.A.; Nguyen, M.H. Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study. Dig. Dis. Sci. 2012, 57, 1373–1383. [Google Scholar] [CrossRef]
  29. Upadhyaya, N.; Chang, R.; Davis, C.; Conti, M.C.; Salinas-Garcia, D.; Tang, H. Chronic Hepatitis B: Perceptions in Asian American Communities and Diagnosis and Management Practices Among Primary Care Physicians. Postgrad. Med. 2010, 122, 165–175. [Google Scholar] [CrossRef]
  30. Tran, T.T. Understanding Cultural Barriers in Hepatitis B Virus Infection. Cleve. Clin. J. Med. 2009, 76, S10–S13. [Google Scholar] [CrossRef] [Green Version]
  31. Xu, J.J.; Tien, C.; Chang, M.; Rhee, J.; Tien, A.; Bae, H.S.; Ho, F.C.-S.; Chan, L.S.; Fong, T.-L. Demographic and Serological Characteristics of Asian Americans with Hepatitis B Infection Diagnosed at Community Screenings. J. Viral Hepat. 2013, 20, 575–581. [Google Scholar] [CrossRef]
  32. Tokes, K.; Quadri, S.; Cahill, P.; Chiu, G.; Ivanov, A.; Tang, H. Disease and Treatment Perceptions Among Asian Americans Diagnosed with Chronic Hepatitis B Infection. J. Gen. Intern. Med. 2014, 29, 477–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Ispas, S.; So, S.; Toy, M. Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. J. Community Health 2019, 44, 610–625. [Google Scholar] [CrossRef] [PubMed]
  34. Hwang, J.P.; Roundtree, A.K.; Suarez-Almazor, M.E. Attitudes Toward Hepatitis B Virus among Vietnamese, Chinese and Korean Americans in the Houston Area, Texas. J. Community Health 2012, 37, 1091–1100. [Google Scholar] [CrossRef]
  35. Ha, N.B.; Trinh, H.N.; Nguyen, T.T.; Leduc, T.-S.; Bui, C.; Ha, N.B.; Wong, C.R.; Tran, A.T.; Nguyen, M.H. Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California. J. Cancer Educ. 2013, 28, 319–324. [Google Scholar] [CrossRef] [PubMed]
  36. Burke, N.J.; Do, H.H.; Talbot, J.; Sos, C.; Svy, D.; Taylor, V.M. Chumnguh Thleum: Understanding Liver Illness and Hepatitis B among Cambodian Immigrants. J. Community Health 2011, 36, 27–34. [Google Scholar] [CrossRef] [Green Version]
  37. Kong, L.-N.; Yao, Y.; Li, L.; Zhao, Q.-H.; Wang, T.; Li, Y.-L. Psychological Distress and Self-management Behaviours among Patients with Chronic Hepatitis B Receiving Oral Antiviral Therapy. J. Adv. Nurs. 2021, 77, 266–274. [Google Scholar] [CrossRef]
  38. Hajarizadeh, B.; Wallace, J.; Richmond, J.; Ngo, N.; Enright, C. Hepatitis B Knowledge and Associated Factors among People with Chronic Hepatitis B. Aust. N. Z. J. Public Health 2015, 39, 563–568. [Google Scholar] [CrossRef]
  39. Osborn, C.Y.; Egede, L.E. Validation of an Information–Motivation–Behavioral Skills Model of Diabetes Self-Care (IMB-DSC). Patient Educ. Couns. 2010, 79, 49–54. [Google Scholar] [CrossRef] [Green Version]
  40. Tsamlag, L.; Wang, H.; Shen, Q.; Shi, Y.; Zhang, S.; Chang, R.; Liu, X.; Shen, T.; Cai, Y. Applying the Information–Motivation–Behavioral Model to Explore the Influencing Factors of Self-Management Behavior among Osteoporosis Patients. BMC Public Health 2020, 20, 198. [Google Scholar] [CrossRef]
  41. Blackstock, O.J.; Platt, J.; Golub, S.A.; Anakaraonye, A.R.; Norton, B.L.; Walters, S.M.; Sevelius, J.M.; Cunningham, C.O. A Pilot Study to Evaluate a Novel Pre-Exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS Behav. 2021, 25, 1411–1422. [Google Scholar] [CrossRef]
  42. Patel, V.V.; Rawat, S.; Dange, A.; Lelutiu-Weinberger, C.; Golub, S.A. An Internet-Based, Peer-Delivered Messaging Intervention for HIV Testing and Condom Use Among Men Who Have Sex With Men in India (CHALO!): Pilot Randomized Comparative Trial. JMIR Public Health Surveill. 2020, 6, e16494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Lelutiu-Weinberger, C.; Pachankis, J.E.; Gamarel, K.E.; Surace, A.; Golub, S.A.; Parsons, J.T. Feasibility, Acceptability, and Preliminary Efficacy of a Live-Chat Social Media Intervention to Reduce HIV Risk Among Young Men Who Have Sex With Men. AIDS Behav. 2015, 19, 1214–1227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Gavgani, R.M.; Poursharifi, H.; Aliasgarzadeh, A. Effectiveness of Information-Motivation and Behavioral Skill (IMB) Model in Improving Self-Care Behaviors & Hba1c Measure in Adults with Type2 Diabetes in Iran-Tabriz. Procedia-Soc. Behav. Sci. 2010, 5, 1868–1873. [Google Scholar] [CrossRef] [Green Version]
  45. Nelson, L.A.; Wallston, K.A.; Kripalani, S.; LeStourgeon, L.M.; Williamson, S.E.; Mayberry, L.S. Assessing Barriers to Diabetes Medication Adherence Using the Information-Motivation-Behavioral Skills Model. Diabetes Res. Clin. Pract. 2018, 142, 374–384. [Google Scholar] [CrossRef]
  46. Ma, G.X.; Tan, Y.; Zhu, L.; Wang, M.Q.; Zhai, S.; Yu, J.; Seals, B.; Siu, P.; Ma, X.; Fang, C.; et al. Testing a Program to Help Monitor Chronic Hepatitis B among Asian-American Patients; Patient-Centered Outcomes Research Institute (PCORI): Washington, DC, USA, 2020. [Google Scholar]
  47. Ogedegbe, G.; Mancuso, C.A.; Allegrante, J.P.; Charlson, M.E. Development and Evaluation of a Medication Adherence Self-Efficacy Scale in Hypertensive African-American Patients. J. Clin. Epidemiol. 2003, 56, 520–529. [Google Scholar] [CrossRef]
  48. StataCorp. Stata Statistical Software: Release 16; StataCorp LLC: College Station, TX, USA, 2019. [Google Scholar]
  49. Ye, J.; Mack, D.; Fry-Johnson, Y.; Parker, K. Health Care Access and Utilization among US-Born and Foreign-Born Asian Americans. J. Immigr. Minor. Health 2012, 14, 731–737. [Google Scholar] [CrossRef] [Green Version]
  50. Jang, Y.; Park, N.S.; Yoon, H.; Huang, Y.; Rhee, M.; Chiriboga, D.A.; Kim, M.T. The Risk Typology of Healthcare Access and Its Association with Unmet Healthcare Needs in Asian Americans. Health Soc. Care Community 2018, 26, 72–79. [Google Scholar] [CrossRef]
  51. Ma, K.P.K.; Bacong, A.M.; Kwon, S.C.; Yi, S.S.; Ðoàn, L.N. The Impact of Structural Inequities on Older Asian Americans during COVID-19. Front. Public Health 2021, 9, 1183. [Google Scholar] [CrossRef]
  52. Brown, A.F.; Ma, G.X.; Miranda, J.; Eng, E.; Castille, D.; Brockie, T.; Jones, P.; Airhihenbuwa, C.O.; Farhat, T.; Zhu, L.; et al. Structural Interventions to Reduce and Eliminate Health Disparities. Am. J. Public Health 2019, 109, S72–S78. [Google Scholar] [CrossRef]
Table
Table 1. Sociodemographic and psychosocial factors among participants who had visited doctors in the past six months for their CHB and those who did not.
Table 1. Sociodemographic and psychosocial factors among participants who had visited doctors in the past six months for their CHB and those who did not.
Visited Doctor for CHB
(n = 132)		No Visit
(n = 246)		 χ 2   ( d f )   o r   t   ( d f ) ,   p
Sociodemographic characteristicsn (%) or mean (sd)
Age54.26 (13.92)52.75 (13.30)−1.03 (376), 0.30
Gender 0.49 (1), 0.48
         Female71 (36.60%%)123 (63.40%)
         Male61 (33.15%)123 (66.85%)
Ethnicity 9.76 (1), 0.002
         Chinese115 (38.98%)180 (61.02%)
         Vietnamese17 (20.48%)66 (79.52%)
Marital status 1.95 (1), 0.16
         Currently married/cohabitating111 (36.39%)194 (63.61%)
         Other19 (27.54%)50 (72.46%)
Born in the US 0.50 (1), 0.48
         No131 (35.12%)242 (64.88%)
         Yes1 (20.00%)4 (80.00%)
Years lived in the US 1.50 (1), 0.22
         <10 years13 (27.66%)34 (72.34%)
         ≥10 years116 (36.83%)199 (63.17%)
Educational attainment 7.25 (1), 0.01
         ≤high school103 (39.31%)159 (60.69%)
         ≥college29 (25.00%)87 (75.00%)
Employment status 1.58 (2), 0.45
         Employed 78 (33.33%)156 (66.67%)
         Unemployed9 (32.14%)19 (67.86%)
         Not in labor force44 (40.00%)66 (60.00%)
Annual household income <0.001 (1), 0.99
         0–$19,99967 (34.90%)125 (65.10%)
         ≥$20,00065 (34.95%)121 (65.05%)
Having health insurance 12.15 (1), <0.001
         No8 (14.29%)48 (85.71%)
         Yes123 (38.32%)198 (61.68%)
Having a regular physician 12.83 (1), <0.001
         No6 (12.24%)43 (87.76%)
         Yes116 (38.54%)185 (61.46%)
Psychosocial factors
HBV-related knowledge5.92 (2.11)5.29 (2.54)−2.38 (360), 0.02
CHB management motivation28.80 (7.04)26.02 (6.73)−3.69 (359), <0.001
CHB management self-efficacy6.02 (6.41)3.62 (6.42)−3.36 (353), <0.001
Table
Table 2. Sociodemographic and psychosocial factors among participants who had blood tests done in the past six months and those who did not.
Table 2. Sociodemographic and psychosocial factors among participants who had blood tests done in the past six months and those who did not.
Had Blood Tests Done
(n = 177)		No Tests
(n = 188)		 χ 2   ( d f ) o r   t   ( d f ) ,   p
Sociodemographic characteristicsn (%) or mean (sd)
Age52.66 (13.59)53.97 (13.32)0.93 (363), 0.35
Gender 0.34 (1), 0.56
        Female93 (50.00%)93 (50.00%)
        Male84 (46.93%)95 (53.07%)
Ethnicity 40.60 (1), <0.001
        Chinese163 (57.39%)121 (42.61%)
        Vietnamese14 (17.28%)67 (82.72%)
Marital status 1.72 (1), 0.19
        Currently married/cohabitating147 (50.00%)147 (50.00%)
        Other28 (41.18%)40 (58.82%)
Born in the US 1.65 (1), 0.20
        No176 (48.89%)184 (51.11%)
        Yes1 (20.00%)4 (80.00%)
Years lived in the US 3.37 (1), 0.07
        <10 years17 (36.96%)29 (63.04%)
        ≥10 years156 (51.49%)147 (48.51%)
Educational attainment 7.82 (1), 0.01
        ≤high school135 (53.36%)118 (46.64%)
        ≥college42 (37.50%)70 (62.50%)
Employment status 5.54 (2), 0.06
        Employed 105 (46.67%)120 (53.33%)
        Unemployed9 (33.33%)18 (66.67%)
        Not in labor force61 (56.48%)47 (43.52%)
Annual household income .02 (1), 0.89
        0–$19,99990 (48.13%)97 (51.87%)
        ≥$20,00087 (48.88%)91 (51.12%)
Having health insurance 10.75 (1), 0.001
        No15 (27.78%)39 (72.22%)
        Yes161 (51.94%)149 (48.06%)
Having a regular physician 17.11 (1), <0.001
        No10 (21.28%)37 (78.72%)
        Yes156 (53.79%)134 (46.21%)
Psychosocial factors
HBV-related knowledge5.76 (2.04)5.24 (2.70)−2.02 (348), 0.04
CHB management motivation29.47 (7.37)24.77 (5.83)−6.64 (347), <0.001
CHB management self-efficacy6.44 (7.12)2.70 (5.40)−5.50 (341), <0.001
Table
Table 3. Multivariate logistic regression results on doctor visit and blood test.
Table 3. Multivariate logistic regression results on doctor visit and blood test.
Had Visited Doctor for CHBHad Blood Tests Done
predictorsOR (95% CI)
Female gender (ref: male)1.23 (0.68–2.23)1.44 (.74–2.78)
Vietnamese ethnicity (ref: Chinese)0.62 (0.22–1.73)0.03 (0.01–10) ***
College degree or above (ref: <= high school)0.50 (0.22–1.12)0.37 (0.15–90) *
Lived in the US for 10+ years (ref: < 10 yrs)1.03 (0.40–2.65)1.35 (0.51–3.61)
Having health insurance (ref: no)2.99 (0.67–5.93)4.34 (1.24–15.27) *
Having a regular physician (ref: no)3.81 (1.21–12.01) *2.91 (0.86–9.89)
Speaking English well/very well (ref: no/poor)0.87 (0.40–1.90)1.41 (0.60–3.32)
HBV-related knowledge 1.24 (1.07–1.45) **1.29 (1.10–1.51) **
CHB-management motivation 1.06 (1.01–1.11) *1.12 (1.06–1.19) ***
CHB-management self-efficacy1.03 (0.98–1.09)1.02 (0.96–1.09)
Constant0.004 ***0.001 ***
n313301
Log likelihood−144.63−126.59
Wald   χ 2 (df), p33.77 (10), <0.00164.89 (10), <0.001
* p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: OR = odds ratio; CI = confidence interval.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ma, G.X.; Zhu, L.; Lu, W.; Tan, Y.; Truehart, J.; Johnson, C.; Handorf, E.; Nguyen, M.T.; Yeh, M.-C.; Wang, M.Q. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. Int. J. Environ. Res. Public Health 2022, 19, 4642. https://doi.org/10.3390/ijerph19084642

AMA Style

Ma GX, Zhu L, Lu W, Tan Y, Truehart J, Johnson C, Handorf E, Nguyen MT, Yeh M-C, Wang MQ. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. International Journal of Environmental Research and Public Health. 2022; 19(8):4642. https://doi.org/10.3390/ijerph19084642

Chicago/Turabian Style

Ma, Grace X., Lin Zhu, Wenyue Lu, Yin Tan, Jade Truehart, Cicely Johnson, Elizabeth Handorf, Minhhuyen T. Nguyen, Ming-Chin Yeh, and Min Qi Wang. 2022. "Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model" International Journal of Environmental Research and Public Health 19, no. 8: 4642. https://doi.org/10.3390/ijerph19084642

APA Style

Ma, G. X., Zhu, L., Lu, W., Tan, Y., Truehart, J., Johnson, C., Handorf, E., Nguyen, M. T., Yeh, M.-C., & Wang, M. Q. (2022). Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. International Journal of Environmental Research and Public Health, 19(8), 4642. https://doi.org/10.3390/ijerph19084642

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop